Supreme Raises

Supreme Court Raises Bar for Pleading Induced Patent Infringement in Hikma v. Amarin

In a unanimous decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., the U.S. Supreme Court refined the legal standard for pleading induced patent infringement under 35 U.S.C. § 271(b). The ruling underscores that plaintiffs must plausibly allege that defendants actively encouraged infringement with knowl…